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Objectives We sought to decipher metabolic processes servicing the increased energy demand during persistent atrial fibril-
lation (AF) and to ascertain whether metabolic derangements might instigate this arrhythmia.
Background Whereas electrical, structural, and contractile remodeling processes are well-recognized contributors to the self-
perpetuating nature of AF, the impact of cardiac metabolism upon the persistence/initiation of this resilient ar-
rhythmia has not been explored in detail.
Methods Human atrial appendage tissues from matched cohorts in sinus rhythm (SR), from those who developed AF post-
operatively, and from patients in persistent AF undergoing cardiac surgery were analyzed using a combined
metabolomic and proteomic approach.
Results High-resolution proton nuclear magnetic resonance (NMR) spectroscopy of cardiac tissue from patients in persis-
tent AF revealed a rise in beta-hydroxybutyrate, the major substrate in ketone body metabolism, along with an
increase in ketogenic amino acids and glycine. These metabolomic findings were substantiated by proteomic
experiments demonstrating differential expression of 3-oxoacid transferase, the key enzyme for ketolytic energy
production. Notably, compared with the SR cohort, the group susceptible to post-operative AF showed a discor-
dant regulation of energy metabolites. Combined principal component and linear discriminant analyses of meta-
bolic profiles from proton NMR spectroscopy correctly classified more than 80% of patients at risk of AF at the
time of coronary artery bypass grafting.
Conclusions The present study characterized the metabolic adaptation to persistent AF, unraveling a potential role for ketone
bodies, and demonstrated that discordant metabolic alterations are evident in individuals susceptible to post-
operative AF. (J Am Coll Cardiol 2008;51:585–94) © 2008 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2007.09.055n
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ptrial fibrillation (AF), the most common arrhythmia
ncountered in clinical practice, results in significant mor-
idity and mortality. A significant proportion of patients with
aroxysmal AF develop persistent or even permanent AF over
ime, but the exact reasons for this remain unknown (1).
Animal models of pacing-induced AF have demonstrated
hat AF is a self-perpetuating arrhythmia (i.e., the longer it
s present, the more persistent it becomes), leading to the
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everal different forms of remodeling within the atria—
lectrical, contractile, and structural (3). Electrical and
ontractile remodeling appear to be closely related through
down-regulation of the L-type Ca2 current and are fully
eversed within a few days of sinus rhythm (SR) having been
estored (4). Structural remodeling, on the other hand,
ncompasses a plethora of potentially irreversible intracel-
ular and extracellular processes (5). Whereas electrical,
tructural, and contractile remodeling processes are well-
ecognized contributors to the self-perpetuating nature of
F, the impact of cardiac metabolism upon the initiation/
ersistence of this resilient arrhythmia has not been ex-
lored in detail.
A recent microarray analysis in patients with perma-ent AF revealed ventricularization of gene expression
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transcripts involved in meta-
bolic activities (6), including
several glycolytic enzymes, sug-
gesting a switch to glucose me-
tabolism in AF. However, de-
duction of metabolic changes
based on messenger ribonucleic
acid transcript analysis requires
confirmation at the protein and
metabolite levels. We previ-
ously demonstrated that the
combined application of new
technologies, such as proteom-
ics and metabolomics, allows
ovel insights into the pathophysiology of various car-
iovascular diseases (7). To further clarify metabolic
rocesses at work during human persistent AF and to
scertain whether metabolic derangements might play a
ole in instigating this resilient arrhythmia, we analyzed
uman atrial tissues from matched cohorts in SR, from
hose who developed AF post-operatively (SR-AF
roup), and from patients in persistent AF (AF group)
sing a combined metabolomic and proteomic approach.
aterials and Methods
atients. Atrial appendages were obtained as surgical spec-
mens from patients undergoing cardiac surgery by use of
stablished procedures approved by our local Regional
thics Committee Board. Informed consent was obtained
rom all patients recruited into the study. All subjects in
he AF cohort had severe nonrheumatic valvular disease
s the principal underlying pathology for surgery. Patients
ith rheumatic valvular disease, mixed valvular pathophys-
ology, impaired glucose tolerance, and diabetes mellitus
ere excluded from the study. Recruited subjects with AF
ad had the documented arrhythmia for at least 1 year
geometric mean 4.4 years). Patients in the SR-AF cohort
ere undergoing either coronary artery bypass grafting
CABG) or valve surgery. For comparison, matched pa-
ients in SR were screened to ensure that they had never
xperienced AF by direct questioning about symptoms
uggestive of such and by the retrospective analysis of all
2-lead electrocardiograms during their entire pre-
perattive review periods. No patients in the SR cohort had
ver been or were on any antiarrhythmic drugs other than
eta-blockers or calcium channel blockers. Cohorts were
atched for those patient characteristics that had been
ighlighted to be relevant by the largest prospective and
ongitudinal multicenter analysis of post-cardiac surgery AF
8). Atrioventricular nodal blocking agents in the AF cohort
ncluded beta-blockers, calcium channel blockers, and
igoxin; no subjects in AF were on other antiarrhythmic
Abbreviations
and Acronyms
AF  atrial fibrillation
CABG  coronary artery
bypass grafting
CRP  C-reactive protein
MALDI  matrix-assisted
laser-desorption ionization
NMR  nuclear magnetic
resonance
PCA  principal component
analysis
SR  sinus rhythmrugs at the time of surgery. Tissue was harvested during oannulation of the right atrium for bypass, and specimens
ere immediately snap-frozen and stored in liquid nitrogen.
roton nuclear magnetic resonance (NMR) spectros-
opy. Snap-frozen hearts were extracted in 6% perchloric
cid (9). Neutralized extracts were freeze-dried and recon-
tituted in deuterium oxide. One-half milliliter of each
xtract was placed in 5-mm NMR tubes. 1H-NMR spectra
ere obtained using a Bruker 600-MHz spectrometer
Bruker BioSpin GmbH, Rheinstetten, Germany). The
ater resonance was suppressed by using gated irradiation
entered on the water frequency. Fifty microliters of 5 mM
odium 3-trimethylsilyl-2,2,3,3-tetradeuteropropionate in
euterium oxide was added to the samples for chemical shift
alibration and quantification. Immediately before the
MR analysis, the pH was readjusted to 7 with perchloric
cid or potassium hydroxide.
roteomic analysis. A detailed methodology for proteomic
nalysis and mass spectrometry is available in the Online
ppendix and on our web site at http://www.vascular-
roteomics.com.
estern blotting. Twenty-five micrograms of protein was
eparated on 8% or 12% Tris-glycine gels (Invitrogen
imited, Paisley, United Kingdom) and blotted to nitrocel-
ulose. Membranes were blocked in 5% phosphate-buffered
aline and milk. Consequently, they were probed with
rimary antibodies to peroxiredoxin 1 (LF-PA0001, 1:100;
ab Frontier, Seoul, Korea), superoxide dismutase (FL-154,
:100; Santa Cruz Biotechnology Inc., Santa Cruz, Califor-
ia), alpha/B crystallin (SPA-223, 1:100; Stressgen, Ann
rbor, Michigan), and desmin (ab8470, 1:200; Abcam,
ambridge, Massachusetts). After incubation with the ap-
ropriate horseradish peroxidase-conjugated secondary
ntibodies, enhanced chemiluminescence (GE Healthcare,
uckinghamshire, United Kingdom) was applied and pro-
eins were detected using X-ray films.
ytokine measurements. Levels of C-reactive protein
CRP), interleukin (IL)-6, and tumor necrosis factor-alpha
TNF-alpha) were measured using commercially available
ssays (Euro/DPC Limited, Gwynedd, United Kingdom)
erformed on an Immulite automated analyzer (Euro/DPC
imited).
tatistical analysis. Statistical analysis of the sample pop-
lations was performed using the Student t test for contin-
ous variables and Fisher exact test for discrete data.
tudent t tests and the nonparametric Mann-Whitney U
est were used to assess protein and metabolite differences in
R and AF cohorts, respectively. Results are given as
ean  SD or SE. A p value 0.05 was considered
ignificant. Statistical analysis of metabolite changes among
ore than 2 groups was performed using analysis of
ariance. This test, however, does not control for multiple
omparisons. The correlation between metabolite ratios and
nset of post-operative AF was estimated by a Pearson
orrelation coefficient. For the calculation of the probability
f metabolite changes being associated with protein changes
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February 5, 2008:585–94 Metabolism in Atrial Fibrillationy chance, simulations were run on Matlab (Mathworks
imited, Cambridge, United Kingdom).
attern recognition. Proton NMR spectroscopy metabolic
rofiles from 1.0 parts per million (ppm) to 4.0 ppm with
ositive intensities scaled to total intensity in the spectrum
ere used for generating bucket tables, producing signals of
00 data points. Principal component analysis (PCA) re-
uced the data dimensionality to 10 variables, enough to
ccurately represent more than 96% of the original data.
inear discriminant analysis (LDA), a classification
ethod, was then applied on the new representation of the
ata. Linear discriminant analysis constructs a separating
yperplane from an optimal projection, which maximizes
he distances between groups while minimizing the dis-
ances within groups (10). The classification results ob-
ained were validated through a leave-one-out scheme, in
hich the classifier was trained and tested n times, respec-
ively, on n  1 and 1 sample to reduce selection bias (11).
esults
atient characteristics. The clinical characteristics of the
ohorts are summarized in the Online Appendix Table 1.
o significant differences were present among the groups
xcept for atrial dilatation and the use of digoxin in patients
ith AF, which are impossible to overcome because persis-
ifferences in Metabolitesetw en Hearts in SR and Permanent AF
Table 1 Differences in MetabolitesBetween Hearts in SR and Permanent AF
SR Valve AF Valve p Value
Leucine 0.070 (0.013) 0.108 (0.020) 0.104
Isoleucine 0.030 (0.011) 0.042 (0.013) 0.318
Valine 0.084 (0.020) 0.128 (0.028) 0.189
Beta-hydroxybutyrate 0.058 (0.021) 0.193 (0.029) 0.006*
Glucose 0.371 (0.074) 0.428 (0.066) 0.462
Lactate 5.198 (0.521) 6.452 (0.766) 0.208
Alanine 1.085 (0.189) 1.296 (0.203) 0.462
Acetate 0.518 (0.140) 0.444 (0.066) 0.916
Glutamate 2.098 (0.395) 2.267 (0.311) 0.834
Succinate 0.740 (0.147) 0.751 (0.134) 0.916
Glutamine 0.929 (0.156) 1.241 (0.240) 0.529
Aspartate 0.135 (0.090) 0.236 (0.072) 0.270
Choline 0.066 (0.015) 0.062 (0.006) 0.753
Phosphocholine 0.099 (0.017) 0.111 (0.011) 0.753
Glycocholic acid 0.591 (0.086) 0.644 (0.147) 0.999
Carnitine 0.365 (0.045) 0.363 (0.050) 0.599
Myoinositol 1.195 (0.273) 1.482 (0.191) 0.401
Taurine 5.576 (0.765) 5.810 (0.848) 0.916
Fumarate 0.003 (0.001) 0.017 (0.009) 0.401
Tyrosine 0.011 (0.004) 0.049 (0.009) 0.002*
Glycine 0.232 (0.052) 0.336 (0.039) 0.016*
Formate 0.617 (0.157) 0.319 (0.041) 0.296
Creatine 1.603 (0.216) 1.482 (0.273) 0.600
Adenosine pool 0.899 (0.100) 1.076 (0.158) 0.401
ata presented are given in mol/g wet weight (mean  SE; N  16, n  8 for patients in SR or
F undergoing valve surgery, respectively). p values were derived from nonparametric Mann-r
hitney U tests. *Statistically significant.
AF  atrial fibrillation; SR  sinus rhythm.ent AF itself leads to and is favored by left atrial dilatation
nd digoxin is predominantly used in AF.
etabolite changes in persistent AF. To analyze meta-
olic alterations in AF, we measured cardiac metabolites
ith high-resolution NMR spectroscopy. A representative
pectrum is shown in Figure 1. Quantitative data for 24
etabolites are presented in Table 1. Concentrations of
eta-hydroxybutyrate were elevated in AF paired with a rise
n ketogenic amino acids (tyrosine and leucine) and increase
n glycine. The latter, along with succinyl-coenzyme A
CoA), contributes all the carbon and nitrogen atoms
equired for the nonhepatic tissue utilization of ketone
odies. Notably, fumarate, a metabolic intermediate in the
ricarboxylic acid (TCA) cycle, became detectable in AF,
esulting in an increase of the fumarate/succinate ratio (p 
.010), similar to what had previously been observed in the
orking rat heart on administration of glucose plus ketone
odies (12,13).
rotein changes in persistent AF. To provide insight into
he consequences of persistent AF on protein expression, we
ompared the proteome of atrial appendages from patients
n SR with those in AF. Protein extracts were separated by
-dimensional gel electrophoresis using a broad pH gradi-
nt (pH 3 to 10 nonlinear) (Fig. 2). Two-dimensional gels
omprised approximately 1,500 protein features. Differen-
ially expressed spots were numbered, excised, and subjected
o in-gel tryptic digestion. Enlarged silver-stained images
re shown in Figure 3A. Protein identifications as obtained
y matrix-assisted laser-desorption ionization-mass spec-
rometry (MALDI-MS) are listed in Table 2. A represen-
ative MALDI-MS spectrum and identifications obtained
y tandem MS are included in the online data supplement
Online Appendix Fig. 1 and Table 2).
Structural damage inflicted by prolonged AF was evident
n 2-dimensional gels as actin, tubulin, and desmin frag-
entation and compensatory changes in small heat shock
roteins, including heat shock protein beta 7 and alpha/B
rystallin. However, no difference in net expression was
bserved for alpha/B crystallin on 1-dimensional sodium
odecyl sulfate polyacrylamide gel electrophoresis (Fig. 3B)
ecause post-translational modifications as well as changes
n net expression can be visualized on 2-dimensional gels.
he structural changes were accompanied by a depletion of
he antioxidant protein peroxiredoxin 1 (spot 14) (Figs. 3A
nd 3B), which is thought to play an important role in
liminating peroxides generated during metabolism (14),
nd a decrease in the levels of the atrial natriuretic peptide
ANP) precursor, which correlates with previous reports
hat AF alters plasma ANP (15). Consistent with our
etabolomic findings, the majority of changes observed in
brillating atria were related to energy metabolism. Among
he differentially expressed enzymes were triose phosphate
somerase (spot 7) (Fig. 3A) and glyceraldehyde-3-
hosphate dehydrogenase (spot 8 to 10) (Fig. 3A), 2
lycolytic enzymes known to be up-regulated as part of the
eprogramming of the human atrial transcriptome in per-
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Metabolism in Atrial Fibrillation February 5, 2008:585–94anent atrial fibrillation (6); 3-oxoacid transferase, the key
nzyme in the extrahepatic utilization of ketone bodies; and
ADH dehydrogenase and ubiquinol cytochrome C reduc-
ase, complex I and III of the respiratory chain, both of
hich are linked via the redox span of the coenzyme Q
ouple. A schematic model of enzyme and metabolite
hanges is shown in Figure 4.
etabolite changes preceding AF. Metabolic changes in
ersistent AF do not allow any conclusions to be made on
heir proarrhythmogenic or antiarrhythmogenic potential.
o determine whether alterations in cardiac metabolism
ight precede the onset of the arrhythmia, we analyzed
trial appendages from patients undergoing CABG who
eveloped AF post-operatively (onset of arrhythmia geo-
etric mean, 2.1 days). Online Appendix Table 3 summa-
izes the clinical characteristics of these patients. Previous
esearch has suggested that the risk of AF post-operatively
orrelates to the amount of inflammation in surgically
reated heart tissues (16). In our cohort, however, post-
perative CRP and cytokine levels (IL-6, TNF-alpha) at
ay 1 after surgery were not significantly different than those
f patients who maintained SR throughout. In contrast,
heir cardiac tissue samples had significantly lower concen-
rations of glucose, beta-hydroxybutyrate, and acetate, an
nd product of lipid metabolism (Online Appendix Table
Figure 1 NMR Spectra of Atrial Appendages
Within the aliphatic and aromatic regions (0.05–9.5 parts per million [ppm]) of t
trimethylsilyl-2,2,3,3-tetradeuteropropionate; (2) leucine; (3) isoleucine; (4) valine;
nate; (11) glutamine; (12) aspartate; (13) creatine and phosphocreatine; (14) cho
glucose; (21) fumarate; (22) tyrosine; (23) AMP, ADP, and ATP; (24) NAD and NAD
within the carnitine peak was ruled out by NMR analysis at low pH. ADP  adenos
adenosine triphosphate; NAD  nicotinamide adenine dinucleotide; NADH  reduc). Cross-validation was performed using PCA to investi- rate the global variation of the 22 patient samples in the
4-dimensional metabolite space (Fig. 5). Principal compo-
ent analysis reduces the dimensionality of a multivariate
ata set by identifying linear combinations of features
metabolites) that provide the most information about
lobal sample variance. A direct comparison with SR
ontrols allowed the occurrence of post-operative AF to be
orrectly classified in 8 of 11 and 9 of 11 patients by PC1
ersus PC5 (Fig. 5B) and PC3 versus PC6 (Fig. 5C),
espectively, with 1 of 11 and 2 of 11 patients maintaining
R being misclassified. Overall, leave-one-out cross-
alidation on both scores correctly classified 81.8% of
atients undergoing CABG surgery.
To explore whether a common signature for post-
perative AF could be identified in patients with different
nderlying pathophysiologies, we collected additional sam-
les from patients who developed arrhythmia after valve
urgery (Online Appendix Table 5). Although tissue levels
f individual metabolites were not significantly altered in
he valve cohort (Online Appendix Table 6), similarities in
etabolite changes, such as reductions in glucose and
reatine levels, were observed to the initial cohort with
oronary artery disease and found to be significant in a
ombined analysis including all SR (n  19) and SR-AF
n  18) patients (Table 3). Furthermore, when ratios
lear magnetic resonance (NMR) spectra, resonances were assigned as: (1) 3-
ta-hydroxybutyrate; (6) lactate; (7) alanine; (8) acetate; (9) glutamate; (10) succi-
5) phosphocholine; (16) carnitine; (17) taurine; (18) glycine; (19) creatine; (20)
) formate; and (26) NAD and NADH. The presence of glycerophosphocholine
hosphate; AF  atrial fibrillation; AMP  adenosine monophosphate; ATP 
m of nicotinamide adenine dinucleotide; SR  sinus rhythm.he nuc
(5) be
line; (1
H; (25
ine dip
ed forather than absolute concentrations were analyzed to com-
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February 5, 2008:585–94 Metabolism in Atrial Fibrillationensate for the observed differences between patients un-
ergoing CABG or valve surgery, the ratio of glucose to
cetate was reduced to a similar extent in all patients who
eveloped post-operative AF, irrespective of the underlying
ardiac pathophysiology (Fig. 6A), and the analysis of all SR
o SR-AF patients was found to be highly significant
1.16  0.32 vs. 0.33  0.13; p  0.006; n  37).
oreover, the ratio of glycolytic end products (alanine,
actate) to end products of lipid metabolism (acetate) cor-
elated positively to the time of onset of post-operative AF
n the CABG group (Fig. 6B), which is consistent with
revious findings in an animal model that glycolytic inhi-
ition predisposes to AF (17). Overall, these findings
rovide additional support for a discordant regulation of
ardiac metabolites before the onset of the arrhythmia and
trongly suggest that metabolite ratios may serve as a better
lassifier for post-operative AF than absolute metabolite
oncentrations.
iscussion
trial fibrillation, as confirmed by recent studies (6), de-
Figure 2 2-Dimensional Gel
Electrophoresis Map of Atrial Appendages
Protein extracts were separated on a pH 3 to 10 nonlinear immobilized pH gra-
dient strip, followed by separation on a 12% sodium dodecyl sulfate polyacryl-
amide gel. Spots were detected by silver staining. The figure represents a
direct overlay of average gels from hearts in sinus rhythm (SR) and atrial fibril-
lation (AF) (blue and orange for SR and AF, respectively) created by using the
Proteomweaver software (Definiens AG, Munich, Germany). Differentially
expressed spots are numbered. Proteins were identified by mass spectrometry
and are listed in Table 2.otes a hypermetabolic state, but how its increased energyequirement is serviced in the long term and whether
etabolism influences the onset or persistence of AF has, to
ur knowledge, not previously been explored. This study in
carefully chosen, well-characterized cohort of patients
ndergoing cardiac surgery used 2 emerging techniques,
roteomics and metabolomics, to provide novel insights into
he metabolic processes at work during AF. Unlike previous
lasma-based metabolomic analyses of myocardial ischemia
18,19), our study applied metabolomic techniques directly
o human cardiac tissue and demonstrated that the com-
ined proteomic and metabolomic platform provides an
xiting armamentarium for investigating cardiovascular pa-
hology (7).
ardiac metabolism in AF. To date, animal studies have
hown that atrial oxygen consumption and coronary flow
ncrease almost 3-fold after the induction of AF; as a
esult, the atrial coronary flow reserve decreases markedly
20,21). Furthermore, high atrial oxygen and energy
Figure 3 Enlargements of Silver-Stained Gels
(A) Representative areas of 2-dimensional gels from patients in SR and AF
highlight quantitative differences in images. Numbers correspond to proteins
listed in Table 2. (B) Quantification of protein abundance using 1-dimensional
sodium dodecyl sulfate polyacrylamide gel electrophoresis. Note the decline of
peroxiredoxin 1 levels in persistent AF. SOD  superoxide dismutase; other
abbreviations as in Figure 2.
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Metabolism in Atrial Fibrillation February 5, 2008:585–94emand during AF result in a transient drop in phospho-
reatine levels during early stages of AF (22), but
hosphocreatine levels are replenished after a few days of
he sustained arrhythmia, a time scale remarkably com-
arable to the reversibility of contractile dysfunction.
ow energy needs of the persistent arrhythmia are
ubsequently met remains unknown. Human studies
easuring coronary arteriovenous differences have re-
orted increased lactate production during AF (23), and
thers increased oxidative stress and impaired myofibril-
ar energetics, which may lead to atrial contractile dys-
unction during AF (24). High energy demand might
xplain many of the permanent changes in the atria
ifferences in Protein Profiles Between Hearts in SR and AF
Table 2 Differences in Protein Profiles Between Hearts in SR a
Spot
No. Protein Identity * p Value NCBI Entry
Myofilaments
1 Tubulin alpha chain
(fragment)
3.3 0.026 55977864 Interm
2 Actin alpha cardiac 2.1 0.031 54036697 Cytosk
3 Actin alpha cardiac
(fragment)
2.6 0.023 54036697 Cytosk
4 Actin alpha cardiac
(fragment)
2.0 0.030 54036697 Cytosk
5 Cardiac myosin light
chain 1
2.3 0.007 127149 Contra
6 Desmin (fragment) 5.3 0.010 23506465 Interm
Glucose metabolism
7 Triosephosphate
isomerase
4.8 0.001 4507645 Glycoly
8 Glyceraldehyde-3-
phosphate
dehydrogenase
2.4 0.002 32891805 Glycoly
9 Glyceraldehyde-3-
phosphate
dehydrogenase
2.6 0.000 32891805 Glycoly
10 Glyceraldehyde-3-
phosphate
dehydrogenase
1.8 0.001 32891805 Glycoly
Lipid metabolism
11 3-Oxoacid transferase 2.0 0.004 4557817 Utilizat
bod
Respiratory chain
12 NADH dehydrogenase
(ubiquinone)
flavoprotein 1
2.1 0.032 15990511 Energy
con
13 Ubiquinol cytochrome C
reductase core
protein I
2.3 0.012 46593007 Energy
con
Other
14 Peroxiredoxin 1 3.0 0.023 32455266 Thiored
pero
15 Crystallin alpha beta AF† 0.020 30582379 Actin p
16 Heat-shock protein
beta-7
2.3 0.024 12643877 Small h
prot
17 Atrial natriuretic
peptide precursor
2.2 0.017 178638 Vasoac
Fold increase/decrease in AF samples (n  8) compared with SR (n  8). †Protein species were
MW  molecular weight; NCBI  National Center for Biotechnology Information; pI  isoelectresulting from persistent AF such as cellular hypertrophy, kyolysis, changes in mitochondrial shape, and perinu-
lear accumulation of glycogen (25).
lucose metabolism in AF. Recent microarray analysis in
atients with permanent AF (6) revealed a prominent
p-regulation of transcripts involved in metabolic activities,
ncluding several glycolytic enzymes. Consistent with these
icroarray data, enzymatic changes constituted the majority
f differences in the protein profiles of human samples of
ersistent AF, and glycolytic enzymes were among the
ifferentially expressed proteins; however, a corresponding
uild-up of glucose metabolites (i.e., lactate or alanine, a
ransamination product of pyruvate) failed to reach statisti-
al significance. The intracellular calcium concentration, a
tion
Calculated pI/MW
(Da  103)
Observed pI/MW
(Da  103)
Sequence Coverage/
Mascot Score
filament 4.9/50.6 5.5/39.7 24%/87 MS/MS‡
5.2/42.3 5.8/41.2 MS/MS‡
5.2/42.3 5.0/32.1 19%/72
5.2/42.3 5.2/33.0 18%/76
5.0/22.1 5.1/24.7 36%/94 MS/MS‡
filament 5.2/53.4 5.0/58.4 35%/120 MS/MS‡
6.5/26.8 6.5/31.0 42%/137
8.2/36.2 7.9/33.0 MS/MS‡
8.2/36.2 7.2/38.0 28%/113
8.2/36.2 7.0/38.0 17%/64
ketone 7.1/56.6 6.7/59.5 16%/89
ction, Fe-S–
protein
8.5/50.5 7.5/52.6 43%/248
ction, Fe-S–
protein
5.9/53.3 5.5/50.2 25%/156
ependent
ductase 2
8.3/22.3 8.1/28.0 37%/105
rization 6.8/20.1 6.9/22.3 25%/64
ock 6.0/18.6 6.4/19.1 MS/MS‡
ptide 5.1/16.5 5.3/19.4 34%/87
able in AF samples only. ‡Identification by tandem mass spectrometry.
; other abbreviations as in Table 1.nd AF
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ight be met by increased glycolysis. However, intracellular
alcium levels normalize in prolonged AF, and perinuclear
torage of glycogen in fibrillating atria continues (27). Two
xplanations have been suggested: cardiac accumulation of
lycogen may be either the result of a metabolic excess
f glucose or the consequence of impaired catabolism of
lycogen (5). Our findings make a metabolic excess of
lucose less likely because tissue concentrations of glu-
ose were unchanged in patients with persistent AF.
etone bodies in AF. Extrahepatic tissues utilize ketone
odies by converting beta-hydroxybutyrate successively to
cetoacetate and acetoacetyl-CoA, which is finally cleaved
o yield 2 molecules of acetyl-CoA for oxidation in the
CA cycle. Among the differentially expressed proteins in
F was 3-oxoacid transferase, a mitochondrial matrix en-
yme required to activate ketones by transferring CoA from
uccinyl-CoA to acetoacetate, the key reaction in ketolytic
nergy production (Fig. 4). Consistent with the proteomic
ndings, metabolomic analysis revealed a rise in the levels of
eta-hydroxybutyrate and ketogenic amino acids, notably
yrosine, which forms acetoacetate and fumarate during
atabolism. Fumarate levels were markedly elevated in
ersistent AF, and consequently the fumarate/succinate
atio increased. The latter is often used as an indicator for
he redox state of the coenzyme Q couple (13), which is the
Figure 4 Representation of Enzyme
and Metabolic Changes in Persistent AF
The illustration shows the TCA cycle, oxidative phosphorylation, and protein
and metabolite changes observed in patients with persistent AF (red). Nota-
bly, the probability of 3 metabolites being associated with 3 enzymes out of
the 17 differentially expressed proteins by chance was estimated at 5%
after running 1 million simulations on Matlab (Mathworks Limited). Each
simulation consisted of randomly selecting 3 metabolites out of the 24
measured, generating 1,500 proteins, randomly associating 300 of them
with pairs of metabolites (based on the fact that approximately 20% of
spots on 2-dimensional gel maps from human hearts are metabolic
enzymes), and randomly selecting 17 of the 1,500 proteins. A success was
defined as the 3 selected metabolites being associated with at least 3 pro-
teins among the 17 selected. CoA  coenzyme A; e  electron; TCA  tri-
carboxylic acid; other abbreviations as in Figures 1 and 2.ofactor for the succinate dehydrogenase reaction and links pomplex I and complex III of the respiratory chain via its redox
pan (Fig. 4). Both NADH dehydrogenase (complex I) and
biquinol cytochrome C reductase (complex III) were
mong the differentially expressed proteins in the proteomic
creen. Moreover, animal studies have shown that admin-
stration of glucose plus ketone bodies resulted in an
ncrease in the fumarate/succinate ratio similar to our
bservation in humans (13). Thus, there are several lines of
vidence to suggest that ketone bodies might be an impor-
ant fuel during human persistent AF.
nergy metabolism in AF. As beta-hydroxybutyrate is
ore reduced, it provides 30% more calories per carbon unit
han pyruvate, the normal mitochondrial fuel produced by
lycolysis (13). The higher inherent energy present in
etone bodies exerts a glucose-sparing effect in cardiac
uscle mediated by increased acetyl-CoA, which competes
ith CoA for binding to the pyruvate dehydrogenase
omplex (28). The pyruvate dehydrogenase complex is
esponsible for converting pyruvate into acetyl-CoA, repre-
enting the irreversible step from glycolysis to the TCA
ycle. A previous transcript analysis of human persistent AF
6) revealed that, along with several glycolytic enzymes,
yruvate dehydrogenase kinase 1, which inactivates the
yruvate dehydrogenase complex, was up-regulated,
hereas pyruvate dehydrogenase phosphatase, which re-
erses this inhibition, was down-regulated in AF. Phos-
horylation of the pyruvate dehydrogenase complex would
mpair the coupling of glycolysis to the mitochondrial TCA
ycle, and as a result, raising myocardial levels of glucose
-phosphate would reroute glucose toward glycogen synthe-
is (28). Indeed, previous animal experiments confirmed
hat addition of ketones to glucose perfusion results in a
witch from constant glycogen breakdown to glycogen
ynthesis in working hearts (12), and increased expression of
lycogen synthase was observed in human AF, accompanied
y a corresponding down-regulation of glycogen phosphor-
lase, the enzyme responsible for glycogen breakdown (6).
aken together, the proteomic, metabolomic, and transcrip-
omic data on human AF would be consistent with a
egative feedback of ketone bodies on glucose metabolism.
Instead, the observed compensatory up-regulation of
lycolytic enzymes during persistent AF (6) might be
equired to fill up TCA cycle intermediates. Under nor-
oxic conditions, pyruvate is not only decarboxylated but
lso carboxylated to oxaloacetate and malate, allowing the
eplenishment of TCA cycle intermediates and recycling of
arbon dioxide (28). Such anaplerotic mechanisms appear to
e particularly important during prolonged oxidation of
etone bodies, which can “unspan” the Krebs cycle by
equestration of CoA, thereby impairing the energy produc-
ion required to sustain contractile performance of the heart
29). Thus, metabolic changes during persistent AF may
ontribute to the self-perpetuating nature of this resilient
rrhythmia.
ost-operative AF. Post-operative AF is a frequent com-
lication of most types of cardiac surgery, occurring in up to
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rofiles from proton NMR spectroscopy, as highlighted in
his study, were able to correctly classify more than 80% of
he patients susceptible to post-operative AF undergoing
ABG. A tendency toward lower glucose and creatine
oncentrations was also observed in patients who developed
ost-operative AF with underlying valve disease. This
pproach at validating our findings in a valve cohort was
dopted to ensure that the differences observed were not
schemia driven. However, valve surgery in itself is associ-
ted with a much higher risk of post-operative AF, and the
ifferent underlying pathophysiologies were associated with
ariable metabolite concentrations (Table 3). Therefore,
etabolite ratios were assessed in all groups, and these, by
iminishing interindividual variability in cohorts, were
ound to provide a better classifier for post-operative AF,
rrespective of the underlying pathology.
Although persistent AF is a distinct clinical entity, our
dditional analysis of atrial appendages of patients who were
n SR at the time of surgery but developed AF post-
peratively provides evidence that metabolic alterations
ight facilitate the onset of the arrhythmia. This assump-
ion is supported by the recent demonstration in an animal
odel that glycolytic inhibition predisposes to AF (17).
imilarly, we found that the lower the ratio of glycolytic end
etabolite Concentrations in Atria of SR Patients Undergoing CAB
Table 3 Metabolite Concentrations in Atria of SR Patients Und
SR SR-AF SR
CABG (n  11) CABG (n  11) Valve (n
Leucine 0.056 (0.012) 0.041 (0.016) 0.070 (
Isoleucine 0.018 (0.006) 0.010 (0.004) 0.030 (
Valine 0.045 (0.012) 0.029 (0.011) 0.084 (
Beta-hydroxybutyrate 0.051 (0.016) 0.002 (0.002) 0.058 (
Glucose 0.256 (0.065) 0.079 (0.020) 0.371 (
Lactate 5.266 (1.650) 1.334 (0.380) 5.198 (
Alanine 1.220 (0.317) 0.609 (0.193) 1.085 (
Acetate 0.413 (0.074) 0.202 (0.028) 0.518 (
Glutamate 1.060 (0.275) 0.428 (0.122) 2.098 (
Succinate 0.883 (0.119) 0.566 (0.093) 0.740 (
Glutamine 0.576 (0.146) 0.229 (0.080) 0.929 (
Aspartate 0.134 (0.043) 0.044 (0.020) 0.135 (
Choline 0.041 (0.013) 0.030 (0.010) 0.066 (
Phosphocholine 0.067 (0.016) 0.031 (0.009) 0.099 (
Glycocholic acid 0.634 (0.066) 0.611 (0.066) 0.591 (
Carnitine 0.222 (0.051) 0.098 (0.022) 0.365 (
Myoinositol 1.168 (0.296) 0.502 (0.151) 1.195 (
Taurine 3.282 (0.949) 2.013 (0.693) 5.576 (
Fumarate 0.003 (0.002) 0.001 (0.001) 0.003 (
Tyrosine 0.015 (0.004) 0.012 (0.009) 0.011 (
Glycine 0.326 (0.086) 0.301 (0.061) 0.232 (
Formate 0.694 (0.086) 0.576 (0.074) 0.617 (
Creatine 0.985 (0.212) 0.600 (0.145) 1.603 (
Adenosine pool 0.773 (0.212) 0.422 (0.129) 0.899 (
ata presented are given in mol/g wet weight (mean  SE). p values for differences between SR
nd SR-AF (n 18) cohorts were derived from unpaired t tests; differences among all groups wer
ANOVA  analysis of variance; CABG  coronary artery bypass grafting; SR-AF  post-operativroducts to end products of lipid metabolism in human strial tissue, the earlier the onset of the arrhythmia in
ABG patients. The higher incidence of post-operative AF
n the valve cohort excluded it from the time of onset
nalysis. To date, CRP levels have been shown to correlate
ot only with the risk of post-operative AF but also with its
eak incidence (16). To our knowledge, this is the first
vidence that alterations in tissue metabolites might serve as
lassifiers for post-operative AF. Although a link between
issue metabolism and inflammation has been established in
keletal muscle (30), it has yet to be proven in cardiac tissue,
specially with respect to AF.
tudy limitations. During the course of this study, to
nhance pathway discovery, we performed an in-depth
nalysis of extremely well-matched but admittedly small
ohorts of patients undergoing cardiac surgery. The heter-
geneous nature of AF means that despite the sample size of
his study (n  45) exceeding any previous metabolomic
tudies using human cardiac tissue samples, the assessment
f the impact of different underlying mechanisms on me-
abolism will require future exploration in larger indepen-
ent data sets. Furthermore, NMR currently only monitors
pproximately 20 to 30 of the most abundant metabolites,
nd the predictive value of absolute metabolite concentra-
ions is hindered by the different pathophysiologies them-
elves expressing variable metabolic profiles. More sensitive
Valve Surgery
ng CABG or Valve Surgery
SR-AF p Value
Valve (n  7) CABG vs. Valve SR vs. SR-AF ANOVA
) 0.060 (0.024) 0.301 0.411 0.641
) 0.026 (0.012) 0.080 0.415 0.303
) 0.084 (0.027) 0.007* 0.561 0.055
) 0.045 (0.022) 0.135 0.041 0.058
) 0.242 (0.079) 0.035* 0.016* 0.014*
) 5.224 (1.856) 0.158 0.084 0.064
) 1.198 (0.299) 0.407 0.246 0.282
) 0.917 (0.245) 0.005* 0.807 0.004*
) 1.950 (0.663) 0.001* 0.269 0.008*
) 0.975 (0.168) 0.266 0.673 0.174
) 0.828 (0.254) 0.005* 0.146 0.015*
) 0.174 (0.082) 0.169 0.432 0.221
) 0.065 (0.020) 0.038* 0.589 0.212
) 0.084 (0.021) 0.011* 0.100 0.022*
) 0.852 (0.203) 0.400 0.370 0.343
) 0.329 (0.094) 0.002* 0.140 0.005*
) 1.082 (0.294) 0.257 0.098 0.170
) 5.255 (1.566) 0.007* 0.376 0.047*
) 0.004 (0.002) 0.411 0.437 0.561
) 0.017 (0.007) 0.979 0.842 0.918
) 0.233 (0.047) 0.231 0.869 0.690
) 1.022 (0.313) 0.298 0.540 0.249
) 0.966 (0.257) 0.021* 0.029* 0.015*
) 0.896 (0.267) 0.115 0.266 0.215
ts undergoing surgery for CABG (n  22) and valve disease (n  15) and combined SR (n  19)
d from ANOVA tables. *Statistically significant.
fibrillation; other abbreviations as in Table 1.G or
ergoi
 8)
0.013
0.011
0.020
0.021
0.074
0.521
0.189
0.140
0.395
0.147
0.156
0.032
0.015
0.017
0.086
0.045
0.273
0.765
0.001
0.004
0.052
0.157
0.216
0.100
patienystems, however, are rapidly evolving, and the usefulness of
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e determined (7).
linical implications. A considerable lag in recovery from
ontractile dysfunction prevails following restoration of SR
rom prolonged AF, and accumulation of lactate and in-
reased oxidative stress have both been implicated in myo-
Figure 5 Pattern Recognition Analysis
1H-NMR metabolite profiles underwent principal component analysis as
described in “Materials and Methods.” (A) Plots of the 4 principal components
(PC 1, 3, 5, and 6) were used for discrimination. Red triangles and blue cir-
cles represent patients who developed post-operative AF and patients, who
maintained SR, respectively. Note that more than 80% of patients were cor-
rectly classified using either PC1 versus PC5 (B) or PC3 versus PC6 (C).
Abbreviations as in Figure 2.aardial contractile dysfunction (24). Although the combined
se of glucose and ketone bodies increases cardiac efficiency
13), oxidation of ketones as a sole substrate can also lead to
ardiac contractile failure (28,31) and increased risk of
rrhythmogenesis through accumulation of glycogen (32).
hus, metabolic alterations occurring during AF may be
losely associated with contractile dysfunction and the
enesis of re-entrant circuits providing possible new expla-
ations to understanding the self-perpetuating nature of this
rrhythmia.
ummary. This study is, to our knowledge, the first
etabolomic and proteomic analysis into human AF
haracterizing the metabolic adaptation processes at work
n persistent AF. It unravels a potential role for ketone
odies and demonstrates that a discordant regulation of
nergy metabolites precedes the onset of the arrhythmia
Figure 6 Metabolite Ratios
(A) Reduction of the glucose to acetate ratio in patients susceptible to post-
operative AF irrespective of the underlying cardiac pathology. (B) Positive corre-
lation between the ratio of glycolytic end products (alanine, lactate) to end
products of lipid metabolism (acetate) and the onset of post-operative AF in
patients with coronary artery disease. ANOVA  analysis of variance; CABG 
coronary artery bypass grafting; other abbreviations as in Figure 2.fter surgery. As such, metabolic profiles might help to
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